344 related articles for article (PubMed ID: 22056791)
21. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
23. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
Iványi B
Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
[TBL] [Abstract][Full Text] [Related]
24. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.
Yao Y; Wang SX; Zhang YK; Qu Z; Liu G; Zou WZ
Nephrol Dial Transplant; 2013 Mar; 28(3):689-97. PubMed ID: 23182813
[TBL] [Abstract][Full Text] [Related]
25. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
Sinclair D; Wainwright L
Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
[TBL] [Abstract][Full Text] [Related]
26. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin light chain nephropathies.
Sturgill BC; Tucker FL; Bolton WK
Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
[TBL] [Abstract][Full Text] [Related]
28. Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis.
Zhu X; Liu F; Liu Y; Liu H; Xu X; Peng Y; Sun L; Yuan S
Clin Lab; 2011; 57(11-12):947-52. PubMed ID: 22239026
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.
Eirin A; Irazabal MV; Gertz MA; Dispenzieri A; Lacy MQ; Kumar S; Sethi S; Nasr SH; Cornell LD; Fidler ME; Fervenza FC; Leung N
Nephrol Dial Transplant; 2012 Mar; 27(3):1097-101. PubMed ID: 22067518
[TBL] [Abstract][Full Text] [Related]
30. The urine light chain/glomerular filtration rate (GFR) quotient shows a high sensitivity and specificity to detect cast nephropathy in monoclonal light chain disease.
Bergner R; Hoffmann M; Uppenkamp M; Paschka P; Klank D
Eur J Haematol; 2021 Jun; 106(6):836-841. PubMed ID: 33725381
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal gammopathy: significance and possible causality in renal disease.
Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
[TBL] [Abstract][Full Text] [Related]
32. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
34. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.
Gu X; Barrios R; Cartwright J; Font RL; Truong L; Herrera GA
Hum Pathol; 2003 Mar; 34(3):270-7. PubMed ID: 12673562
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
[TBL] [Abstract][Full Text] [Related]
36. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
37. Light chain nephropathy: histological and clinical aspects in 15 cases.
Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
[TBL] [Abstract][Full Text] [Related]
38. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
[TBL] [Abstract][Full Text] [Related]
39. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
